August 16, 2021

Windlas Biotech off to a weak begin, lists at 5{bce2ac57dae147ae13b811f47f24d80c66c6ab504b39dda4a9b6e8ac93725942} low cost to subject worth



Shares of Windlas Biotech (WBL) made a disappointing debut on Monday, because the shares of the corporate listed at Rs 437, 5 per cent under its subject worth of Rs 460 on the Nationwide Inventory Trade (NSE). The inventory of the prescribed drugs firm, in the meantime, opened at Rs 439 on the BSE.


At 10:19, WBL was buying and selling at Rs 431, down 6 per cent in opposition to the problem worth on the NSE. The inventory hit a excessive of Rs 452 and a low of Rs 405 up to now in commerce. A mixed 1.9 million fairness shares have modified arms on the counter on the NSE and BSE.





The preliminary public supply (IPO) of WBL bought a good response from the buyers as the problem bought subscribed 22.44 instances. The certified institutional consumers